A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer
暂无分享,去创建一个
D. Kerr | D. Richel | G. Groenewegen | T. Maughan | C. Punt | N. Steven | S. Falk | D. Sémiond | J. Bakker | J. Smit | D. Rea | J. Nortier | W. B. Huinink | D. Semiond